DISPARATE HISTOLOGIC RESPONSES IN SIMULTANEOUSLY RESECTED PRIMARY AND METASTATIC OSTEOSARCOMA FOLLOWING INTRAVENOUS NEOADJUVANT CHEMOTHERAPY

被引：38

作者：

NACHMAN, J

SIMON, MA

DEAN, L

SHERMETA, D

DAWSON, P

VOGELZANG, NJ

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT PEDIAT,CHICAGO,IL 60637

[2] UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,CHICAGO,IL 60637

[3] UNIV CHICAGO,PRITZKER SCH MED,DEPT SURG,CHICAGO,IL 60637

[4] UNIV CHICAGO,PRITZKER SCH MED,DEPT PATHOL,CHICAGO,IL 60637

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 08期

关键词：

D O I：

10.1200/JCO.1987.5.8.1185

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1185 / 1190

页数：6

共 13 条

[1]

KALIFA C, 1986, P INT SOC PEDIATR ON, V5, P104

[2] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY [J].

LINK, MP ;

GOORIN, AM ;

MISER, AW ;

GREEN, AA ;

PRATT, CB ;

BELASCO, JB ;

PRITCHARD, J ;

MALPAS, JS ;

BAKER, AR ;

KIRKPATRICK, JA ;

AYALA, AG ;

SHUSTER, JJ ;

ABELSON, HT ;

SIMONE, JV ;

VIETTI, TJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) :1600-1606

[3]

PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO

[4]

2-6

[5]

ROSEN G, 1979, CANCER-AM CANCER SOC, V43, P2163, DOI 10.1002/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO

[6]

2-S

[7] PRIMARY OSTEOGENIC-SARCOMA OF THE FEMUR - A MODEL FOR THE USE OF PREOPERATIVE CHEMOTHERAPY IN HIGH-RISK MALIGNANT-TUMORS [J].

ROSEN, G ;

CAPARROS, B ;

GROSHEN, S ;

NIRENBERG, A ;

CACAVIO, A ;

MARCOVE, RC ;

LANE, JM ;

HUVOS, AG .

CANCER INVESTIGATION, 1984, 2 (03) :181-192

[8]

ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO

[9]

2-E

[10] HUMAN-TUMOR CELL HETEROGENEITY AND METASTASIS [J].

SPREMULLI, EN ;

DEXTER, DL .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (08) :496-509

← 1 2 →